Showing results (211-220 of 221) with videos related to
Sort By:
Pageof 23
Hepatology (Baltimore, Md.)|March 8, 2000
Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in miceA Nagler, M Pines, U Abadi, et al.Hepatology (Baltimore, Md.)|May 15, 1998
Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenovirusesY Ilan, B Sauter, N R Chowdhury, et al.Occupational and Environmental Medicine|June 20, 2008
Hepatitis B virus, hepatitis C virus and other blood-borne infections in healthcare workers: guidelines for prevention and management in industrialised countriesD FitzSimons, G François, G De Carli, et al.Immunology|June 9, 1998
Human monoclonal antibodies specific to hepatitis B virus generated in a human/mouse radiation chimera: the Trimera systemR Eren, I Lubin, D Terkieltaub, et al.Clinical and Experimental Immunology|April 8, 2015
Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trialE Israeli, E Goldin, S Fishman, et al.Journal of Viral Hepatitis|September 13, 2002
A multicentre, randomized study to evaluate the safety and efficacy of histamine dihydrochloride and interferon-alpha-2b for the treatment of chronic hepatitis CY Lurie, F Nevens, Z G Aprosina, et al.Hepatology (Baltimore, Md.)|January 27, 1999
The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agentsE Ilan, T Burakova, S Dagan, et al.Hepatology (Baltimore, Md.)|August 29, 2000
Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzeesR Eren, E Ilan, O Nussbaum, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 25, 2003
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patientsR N Gunson, D Shouval, M Roggendorf, et al.The Journal of Infectious Diseases|November 24, 1999
Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccineS Frey, R Dagan, Y Ashur, et al.Pageof 23